Actuate Therapeutics ACTU
NASDAQ ACTU
$0.56 -0.05 (-8.75%)
At close: Oct 21, 2026 · 4:00 PM EDT

Actuate Therapeutics (ACTU) Enterprise Value (2024 - 2026)

Updated

Actuate Therapeutics (ACTU) posted Enterprise Value of $32.31 million for Q2 2026, down 72.7% from $118.58 million a year earlier.

Analysis

Actuate Therapeutics (ACTU) Enterprise Value (2024 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Enterprise Value at Actuate Therapeutics was -$4.26 million; for FY2025, it came in at $129.1 million, up 122.6% from FY2024.

  • In prior years, Actuate Therapeutics' Enterprise Value was $58.01 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Actuate Therapeutics 13.81 Mn -27.19 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 32.31 Mn
Dec 31, 2025 129.10 Mn
Sep 30, 2025 138.57 Mn
Jun 30, 2025 118.58 Mn
Mar 31, 2025 128.34 Mn
Dec 31, 2024 58.01 Mn
Sep 30, 2024 66.73 Mn
API Access

Actuate Therapeutics Enterprise Value API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=enterprise-value&ticker=ACTU&period=max&api_key=YOUR_API_KEY